162 related articles for article (PubMed ID: 24845753)
1. A novel approach to block HIV-1 coreceptor CXCR4 in non-toxic manner.
Liu Y; Zhou J; Pan JA; Mabiala P; Guo D
Mol Biotechnol; 2014 Oct; 56(10):890-902. PubMed ID: 24845753
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of HIV-1 fusion with small interfering RNAs targeting the chemokine coreceptor CXCR4.
Zhou N; Fang J; Mukhtar M; Acheampong E; Pomerantz RJ
Gene Ther; 2004 Dec; 11(23):1703-12. PubMed ID: 15306840
[TBL] [Abstract][Full Text] [Related]
3. Evidence for common structural determinants of human immunodeficiency virus type 1 coreceptor activity provided through functional analysis of CCR5/CXCR4 chimeric coreceptors.
Pontow S; Ratner L
J Virol; 2001 Dec; 75(23):11503-14. PubMed ID: 11689632
[TBL] [Abstract][Full Text] [Related]
4. Expression of Nef downregulates CXCR4, the major coreceptor of human immunodeficiency virus, from the surfaces of target cells and thereby enhances resistance to superinfection.
Venzke S; Michel N; Allespach I; Fackler OT; Keppler OT
J Virol; 2006 Nov; 80(22):11141-52. PubMed ID: 16928758
[TBL] [Abstract][Full Text] [Related]
5. Specific transduction of HIV-1 envelope expressing cells by retroviral vectors pseudotyped with hybrid CD4/CXCR4 receptors.
Bittner A; Mitnacht-Kraus R; Schnierle BS
J Virol Methods; 2002 Jun; 104(1):83-92. PubMed ID: 12020795
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of CXCR4 expression by SDF-KDEL in CD34(+) hematopoietic stem cells: An anti-human immunodeficiency virus strategy.
Zhang JC; Sun L; Nie QH; Huang CX; Jia ZS; Wang JP; Lian JQ; Li XH; Wang PZ; Zhang Y; Zhuang Y; Sun YT; Bai X
J Virol Methods; 2009 Oct; 161(1):30-7. PubMed ID: 19463855
[TBL] [Abstract][Full Text] [Related]
7. Distinct functional sites for human immunodeficiency virus type 1 and stromal cell-derived factor 1alpha on CXCR4 transmembrane helical domains.
Tian S; Choi WT; Liu D; Pesavento J; Wang Y; An J; Sodroski JG; Huang Z
J Virol; 2005 Oct; 79(20):12667-73. PubMed ID: 16188969
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 inhibition in cells with CXCR4 mutant genome created by CRISPR-Cas9 and piggyBac recombinant technologies.
Liu S; Wang Q; Yu X; Li Y; Guo Y; Liu Z; Sun F; Hou W; Li C; Wu L; Guo D; Chen S
Sci Rep; 2018 Jun; 8(1):8573. PubMed ID: 29872154
[TBL] [Abstract][Full Text] [Related]
9. Role of the HIV type 1 glycoprotein 120 V3 loop in determining coreceptor usage.
Verrier F; Borman AM; Brand D; Girard M
AIDS Res Hum Retroviruses; 1999 May; 15(8):731-43. PubMed ID: 10357469
[TBL] [Abstract][Full Text] [Related]
10. P2X1 Receptor Antagonists Inhibit HIV-1 Fusion by Blocking Virus-Coreceptor Interactions.
Giroud C; Marin M; Hammonds J; Spearman P; Melikyan GB
J Virol; 2015 Sep; 89(18):9368-82. PubMed ID: 26136569
[TBL] [Abstract][Full Text] [Related]
11. Effect of mutations in the second extracellular loop of CXCR4 on its utilization by human and feline immunodeficiency viruses.
Brelot A; Heveker N; Adema K; Hosie MJ; Willett B; Alizon M
J Virol; 1999 Apr; 73(4):2576-86. PubMed ID: 10074102
[TBL] [Abstract][Full Text] [Related]
12. [Construction of rat CXCR4 gene lentiviral RNA interference vector and its expression in mesenchymal stem cells].
Chen D; Zhang Z; Wu X; Zhang Y
Sheng Wu Gong Cheng Xue Bao; 2009 Feb; 25(2):299-305. PubMed ID: 19459339
[TBL] [Abstract][Full Text] [Related]
13. Human immunodeficiency virus type 1 coreceptor switching: V1/V2 gain-of-fitness mutations compensate for V3 loss-of-fitness mutations.
Pastore C; Nedellec R; Ramos A; Pontow S; Ratner L; Mosier DE
J Virol; 2006 Jan; 80(2):750-8. PubMed ID: 16378977
[TBL] [Abstract][Full Text] [Related]
14. Expression of small hairpin RNA by lentivirus-based vector confers efficient and stable gene-suppression of HIV-1 on human cells including primary non-dividing cells.
Nishitsuji H; Ikeda T; Miyoshi H; Ohashi T; Kannagi M; Masuda T
Microbes Infect; 2004 Jan; 6(1):76-85. PubMed ID: 14738896
[TBL] [Abstract][Full Text] [Related]
15. Mutagenesis of CXCR4 identifies important domains for human immunodeficiency virus type 1 X4 isolate envelope-mediated membrane fusion and virus entry and reveals cryptic coreceptor activity for R5 isolates.
Chabot DJ; Zhang PF; Quinnan GV; Broder CC
J Virol; 1999 Aug; 73(8):6598-609. PubMed ID: 10400757
[TBL] [Abstract][Full Text] [Related]
16. The two human CXCR4 isoforms display different HIV receptor activities: consequences for the emergence of X4 strains.
Duquenne C; Psomas C; Gimenez S; Guigues A; Carles MJ; Barbuat C; Lavigne JP; Sotto A; Reynes J; Guglielmi P; Mettling C; François V; Corbeau P
J Immunol; 2014 Oct; 193(8):4188-94. PubMed ID: 25230750
[TBL] [Abstract][Full Text] [Related]
17. Critical amino acids within the human immunodeficiency virus type 1 envelope glycoprotein V4 N- and C-terminals contribute to virus entry.
Li Y; Yang D; Wang JY; Yao Y; Zhang WZ; Wang LJ; Cheng DC; Yang FK; Zhang FM; Zhuang M; Ling H
PLoS One; 2014; 9(1):e86083. PubMed ID: 24465884
[TBL] [Abstract][Full Text] [Related]
18. Lentiviral vectors that carry anti-HIV shRNAs: problems and solutions.
ter Brake O; Berkhout B
J Gene Med; 2007 Sep; 9(9):743-50. PubMed ID: 17628029
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional regulation of the major HIV-1 coreceptor, CXCR4, by the kappa opioid receptor.
Finley MJ; Steele A; Cornwell WD; Rogers TJ
J Leukoc Biol; 2011 Jul; 90(1):111-21. PubMed ID: 21447649
[TBL] [Abstract][Full Text] [Related]
20. Identification of a subset of human immunodeficiency virus type 1 (HIV-1), HIV-2, and simian immunodeficiency virus strains able to exploit an alternative coreceptor on untransformed human brain and lymphoid cells.
Willey SJ; Reeves JD; Hudson R; Miyake K; Dejucq N; Schols D; De Clercq E; Bell J; McKnight A; Clapham PR
J Virol; 2003 Jun; 77(11):6138-52. PubMed ID: 12743271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
